September 16，The State Council officially approved the China Pharmaceutical Group Corporation and China Biotechnology Group Corporation to implement a joint reorganization。So far，Enterprises that the State -owned Assets Supervision and Administration Commission fulfilled the duties of the investor was adjusted from 136 households to 135 households。It is reported，By the end of this year，Sinopharm Group may also complete stake sports betting appstake betting appthe reorganization of the Shanghai Medical Industry Research Institute。At that time，Three pharmaceutical state -owned enterprises under the SASAC will become one。

   Current，Sinopharm Group's business involves medical circulation、Medical Device、Exhibition Exhibition、Industrial production and other sectors。Medical circulation is its strongest plate，Income accounted for more than 80%of the revenue of Sinopharm Group。Development of biological products such as vaccines、The overall joining of the NCM Group, which is mainly produced，It will directly make up for the shortcomings of the Chinese stake betting appMedicine Stake Sports BettingGroup in the industry。